These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 35854077

  • 21. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
    Leng D, Thanki K, Foged C, Yang M.
    Pharm Res; 2018 Nov 01; 35(12):247. PubMed ID: 30386927
    [Abstract] [Full Text] [Related]

  • 22. Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides.
    Eedara BB, Alabsi W, Encinas-Basurto D, Polt R, Mansour HM.
    AAPS PharmSciTech; 2021 Jun 18; 22(5):185. PubMed ID: 34143327
    [Abstract] [Full Text] [Related]

  • 23. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S, Süverkrüp R, Lamprecht A.
    Int J Pharm; 2020 Aug 30; 586():119564. PubMed ID: 32590097
    [Abstract] [Full Text] [Related]

  • 24. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 30; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 25. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.
    Xu Y, Harinck L, Lokras AG, Gerde P, Selg E, Sjöberg CO, Franzyk H, Thakur A, Foged C.
    Int J Pharm; 2022 Jun 10; 621():121758. PubMed ID: 35483619
    [Abstract] [Full Text] [Related]

  • 26. Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome.
    Boc S, Momin MAM, Farkas DR, Longest W, Hindle M.
    AAPS PharmSciTech; 2021 Apr 15; 22(4):136. PubMed ID: 33860409
    [Abstract] [Full Text] [Related]

  • 27. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
    Odziomek M, Sosnowski TR, Gradoń L.
    Int J Pharm; 2012 Aug 20; 433(1-2):51-9. PubMed ID: 22580211
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
    Pathak V, Park H, Zemlyanov D, Bhujbal SV, Ahmed MU, Azad MAK, Li J, Zhou QT.
    Pharm Res; 2022 Nov 20; 39(11):2781-2799. PubMed ID: 35915320
    [Abstract] [Full Text] [Related]

  • 31. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
    Yang Y, Yang Z, Ren Y, Mei X.
    Drug Deliv; 2014 Sep 20; 21(6):480-6. PubMed ID: 24491208
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J, Chan HK, Gengenbach T, Denman JA.
    Eur J Pharm Biopharm; 2017 Oct 20; 119():224-234. PubMed ID: 28655664
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Optimization of Spray Drying Conditions for Yield, Particle Size and Biological Activity of Thermally Stable Viral Vectors.
    LeClair DA, Cranston ED, Xing Z, Thompson MR.
    Pharm Res; 2016 Nov 20; 33(11):2763-76. PubMed ID: 27450412
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.